Electronic intervention for substance abuse and HIV prevention in men who have sex with men in Argentina
Integration of Electronic SBI(RT) Into an HIV Testing Program to Reduce Substance Use and HIV Risk Behavior Among MSM in Argentina
This study is testing a new tablet-based program to help men who have sex with men in Argentina reduce substance use and risky sexual behaviors while getting HIV testing.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Florida State University Academic / other |
| Locations | 1 site (Buenos Aires) |
| Trial ID | NCT05542914 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and pilot an electronic Screening, Brief Intervention, and Referral to Treatment (e-SBI-RT) program specifically for men who have sex with men (MSM) seeking HIV testing at Nexo Asociacion Civil in Buenos Aires. The program will utilize a tablet-based approach that integrates substance use and sexual risk behavior assessments with tailored Motivational Interviewing (MI). The study will be conducted in two stages: the first stage focuses on developing the e-SBI and training counselors, while the second stage involves a randomized controlled trial to evaluate the feasibility and acceptability of the intervention among participants. Additionally, the study will assess the effectiveness of a four-session MI-based intervention aimed at reducing substance use and risky sexual behaviors.
Who should consider this trial
Good fit: Ideal candidates for this study are men who have sex with men, aged 18 and older, who are seeking an HIV test and report problematic substance use.
Not a fit: Patients who are in need of acute detoxification or have a history of severe withdrawal symptoms may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve access to treatment for substance use and reduce HIV transmission among MSM.
How similar studies have performed: Other studies have shown success with similar electronic interventions for substance use and HIV prevention, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants in Stage 1 Focus Groups (FGs) and in-depth interviews (IDIs): 1. Man who has had sex with men in the past 6 months; 2. 18 years of age or older; 3. Recently sought an HIV test at Nexo; 4. Reports using drugs least once per month in the past 6 months and/or score 4 or greater on the AUDIT C, suggesting moderate risk alcohol use. Participants in Stage 1 e-SBI pilot and the Stage 2 RCT: 1. Man who has had sex with men in the past 6 months 2. 18 years of age or older; 3. Currently seeking an HIV test at Nexo Additional inclusion criteria for MHP entry: 1. Score of moderate or high risk drug or alcohol use based on the ASSIST and AUDIT, respectively Exclusion Criteria: * Exclusion Criteria for MHP entry: 1. be in need of acute detoxification, as demonstrated by physical withdrawal symptoms or a history of withdrawal, such as previous delirium tremens or seizures 2. reported regular use of opioids 3. enrolled in concurrent drug- or alcohol-related treatment.
Where this trial is running
Buenos Aires
- Nexo Asociacion Civil — Buenos Aires, Argentina (Recruiting)
Study contacts
- Principal investigator: Ivan C Balan — Florida State University, College of Medicine
- Study coordinator: Ivan C Research Professor
- Email: ibalan@fsu.edu
- Phone: 2017250565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.